Aggregate reports represent a consolidated overview and detailed assessment of a products’ benefit-risk profile. Qinecsa provides comprehensive end-to-end aggregate reporting management, supported by our team of experts, an array of specialized services and technology.
Our high caliber scientists and physicians are experienced across diverse therapeutic areas and therapy types across all phases of the drug development lifecycle.
Benefit-risk management verifies that the benefits of a medication continue to outweigh the risks, ensuring patient safety with medicinal therapies.
Qinecsa regulatory team are supported by a wide network of consultants and vendor partner network for submission readiness for global agencies including US-FDA, EMA, and MHRA.
2 Leman Street,
London, E1W 9US
United Kingdom
Company number: 13916274